Michael Thomas Schweizer

27PUBLICATIONS
148CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imagingMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 05, 2026
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.

|Aug 13, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.

|Jun 17, 2026
Piggybacking toward Progress for CAR T-Cell Therapy in Prostate Cancer.

|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|Dec 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.

Jeanne M Dsouza, Erolcan Sayar, Michael T Schweizer

|Aug 06, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.

Hyun Jung Lee, Roman Gulati, Erolcan Sayar

Pageof 5

Frequent Collaborators

9 joint publications

Laura S Graham

9 joint publications

Peter S Nelson

8 joint publications

Heather H Cheng

6 joint publications

Tanya Dorff